| Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes M Le Gallo, AJ O'Hara, ML Rudd, ME Urick, NF Hansen, NJ O'Neil, ... Nature Genetics, 2012 | 428 | 2012 |
| PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans A Grall, E Guaguère, S Planchais, S Grond, E Bourrat, I Hausser, C Hitte, ... Nature genetics 44 (2), 140-147, 2012 | 278 | 2012 |
| DNAX accessory molecule‐1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells O Toutirais, F Cabillic, G Le Friec, S Salot, P Loyer, M Le Gallo, M Desille, ... European journal of immunology 39 (5), 1361-1368, 2009 | 143 | 2009 |
| Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas F Bouet-Toussaint, F Cabillic, O Toutirais, M Le Gallo, ... Cancer Immunology, Immunotherapy 57, 531-539, 2008 | 136 | 2008 |
| Identification of a new locus for isolated familial keratoconus at 2p24 H Hutchings, H Ginisty, M Le Gallo, D Levy, F Stoesser, JF Rouland, ... Journal of medical genetics 42 (1), 88-94, 2005 | 122 | 2005 |
| The emerging genomic landscape of endometrial cancer M Le Gallo, DW Bell Clinical chemistry 60 (1), 98-110, 2014 | 112 | 2014 |
| CD95-mediated calcium signaling promotes T helper 17 trafficking to inflamed organs in lupus-prone mice A Poissonnier, D Sanséau, M Le Gallo, M Malleter, N Levoin, R Viel, ... Immunity 45 (1), 209-223, 2016 | 81 | 2016 |
| CD95/Fas, non-apoptotic signaling pathways, and kinases M Le Gallo, A Poissonnier, P Blanco, P Legembre Frontiers in immunology 8, 1216, 2017 | 77 | 2017 |
| Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing M Le Gallo, ML Rudd, ME Urick, NF Hansen, S Zhang, ... Cancer 123 (17), 3261-3268, 2017 | 75 | 2017 |
| Next-generation sequencing M Le Gallo, F Lozy, DW Bell Molecular Genetics of Endometrial Carcinoma, 119-148, 2017 | 58 | 2017 |
| The mutational landscape of endometrial cancer B Hong, M Le Gallo, DW Bell Current opinion in genetics & development 30, 25-31, 2015 | 47 | 2015 |
| A framework for validating AI in precision medicine: considerations from the European ITFoC consortium R Tsopra, X Fernandez, C Luchinat, L Alberghina, H Lehrach, M Vanoni, ... BMC medical informatics and decision making 21, 1-14, 2021 | 38 | 2021 |
| Orexigenic neuropeptide 26RFa: new evidence for an adaptive profile of appetite regulation in anorexia nervosa B Galusca, L Jeandel, N Germain, D Alexandre, J Leprince, Y Anouar, ... The Journal of Clinical Endocrinology & Metabolism 97 (6), 2012-2018, 2012 | 37 | 2012 |
| Sequencing of Candidate Chromosome Instability Genes in Endometrial Cancers Reveals Somatic Mutations in ESCO1, CHTF18, and MRE11A JC Price, LM Pollock, ML Rudd, SK Fogoros, H Mohamed, CL Hanigan, ... PloS one 8 (6), e63313, 2013 | 36 | 2013 |
| The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas M Le Gallo, ML Rudd, ME Urick, NF Hansen, ... Cancer 124 (1), 65-73, 2018 | 35 | 2018 |
| Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer A Almanza, K Mnich, A Blomme, CM Robinson, G Rodriguez-Blanco, ... Nature communications 13 (1), 2493, 2022 | 30 | 2022 |
| Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1 ML Rudd, H Mohamed, JC Price, AJ O’Hara, M Le Gallo, ME Urick, ... BMC cancer 14, 1-9, 2014 | 25 | 2014 |
| HLA-A* 0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy E Fauquembergue, O Toutirais, D Tougeron, A Drouet, M Le Gallo, ... Journal of immunotherapy 33 (4), 402-413, 2010 | 24 | 2010 |
| Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro O Toutirais, A Gervais, F Cabillic, M Le Gallo, A Coudrais, J Leveque, ... Clinical & Experimental Immunology 149 (2), 372-377, 2007 | 24 | 2007 |
| Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases V Risso, E Lafont, M Le Gallo Cell Death & Disease 13 (3), 248, 2022 | 16 | 2022 |
Nigel O'NeilResearch Associate, University of British ColumbiaAdresse e-mail validée de msl.ubc.ca
